Literature DB >> 1717641

Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4.

P D Minor1, M Ferguson, K Katrak, D Wood, A John, J Howlett, G Dunn, K Burke, J W Almond.   

Abstract

Chimeric polioviruses have been made in which regions of the type 1 Sabin strain corresponding to antigenic sites 2, 3 and 4 have been replaced by the corresponding regions of the type 3 Sabin strain. Manipulation of one site or a component of it generally did not affect the reactions of the others, suggesting that they form independent structural features. The extent to which the inserted site expressed the antigenic properties of type 3 could be assessed by reaction with polyclonal or monoclonal antibodies, or by immunogenicity. Site 2 could be expressed on infectious virus and site 3 on heated non-infectious virus (C antigen), but not on the native virion. The results are consistent with the view that sites consisting of a continuous sequence of amino acids may be presented on chimeras, whereas more complex sites, such as site 4 or site 3 of the native virion, are transferred less readily from type 3 to type 1.

Mesh:

Substances:

Year:  1991        PMID: 1717641     DOI: 10.1099/0022-1317-72-10-2475

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.

Authors:  N M Chapman; K S Kim; S Tracy; J Jackson; K Höfling; J S Leser; J Malone; P Kolbeck
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

Authors:  Javier Martín; Elena Samoilovich; Glynis Dunn; Angie Lackenby; Esphir Feldman; Alan Heath; Ekaterina Svirchevskaya; Gill Cooper; Marina Yermalovich; Philip D Minor
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Postinfection treatment with antiviral serum results in survival of neural cells productively infected with virulent poliovirus.

Authors:  E A Tolskaya; T A Ivannikova; M S Kolesnikova; S G Drozdov; V I Agol
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  Widespread circulation of echovirus type 13 demonstrated by increased seroprevalence in Toyama, Japan, between 2000 and 2003.

Authors:  Masae Iwai; Hiromu Yoshida; Mayumi Obara; Eiji Horimoto; Kazuya Nakamura; Takenori Takizawa; Takeshi Kurata; Mineyuki Mizuguchi; Tohru Daikoku; Kimiyasu Shiraki
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

5.  Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.

Authors:  Ke Lyu; Ya-Ling He; Hao-Yang Li; Rong Chen
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

6.  Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.

Authors:  N S Cuervo; S Guillot; N Romanenkova; M Combiescu; A Aubert-Combiescu; M Seghier; V Caro; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV-1) V3 loop seroprevalence library induce neutralizing responses against HIV-1.

Authors:  D A Resnick; A D Smith; S C Gesiler; A Zhang; E Arnold; G F Arnold
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

8.  Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.

Authors:  Chia-Chyi Liu; Meng-Shin Guo; Fion Hsiao-Yu Lin; Kuang-Nan Hsiao; Kate Hsuen-Wen Chang; Ai-Hsiang Chou; Yu-Chao Wang; Yu-Ching Chen; Chung-Shi Yang; Pele Choi-Sing Chong
Journal:  PLoS One       Date:  2011-05-13       Impact factor: 3.240

9.  Comparative Molecular Biology Approaches for the Production of Poliovirus Virus-Like Particles Using Pichia pastoris.

Authors:  Lee Sherry; Keith Grehan; Joseph S Snowden; Michael L Knight; Oluwapelumi O Adeyemi; David J Rowlands; Nicola J Stonehouse
Journal:  mSphere       Date:  2020-03-11       Impact factor: 4.389

10.  Immunological and biochemical characterization of coxsackie virus A16 viral particles.

Authors:  Pele Chong; Meng-Shin Guo; Fion Hsiao-Yu Lin; Kuang-Nan Hsiao; Shu-Yang Weng; Ai-Hsiang Chou; Jen-Ren Wang; Shih-Yang Hsieh; Ih-Jen Su; Chia-Chyi Liu
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.